Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Nov;30(5):769–770. doi: 10.1128/aac.30.5.769

In vitro susceptibility of Acinetobacter species to various antimicrobial agents.

K V Rolston, G P Bodey
PMCID: PMC176529  PMID: 3800353

Abstract

The in vitro activity of 18 antimicrobial agents against 40 clinical isolates each of Acinetobacter calcoaceticus subsp. anitratum and Acinetobacter lwoffi was studied. Most of the newer 4-quinolone derivatives were extremely active against these organisms. Newer beta-lactam agents, such as cefpirome, BMY 28142, and BRL 36650, were also extremely active, inhibiting all strains at clinically achievable levels. Most agents were two- to fourfold more active against A. lwoffi.

Full text

PDF
769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basker M. J., Edmondson R. A., Knott S. J., Ponsford R. J., Slocombe B., White S. J. In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin. Antimicrob Agents Chemother. 1984 Nov;26(5):734–740. doi: 10.1128/aac.26.5.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bodey G. P. Antibiotics in patients with neutropenia. Arch Intern Med. 1984 Sep;144(9):1845–1851. [PubMed] [Google Scholar]
  3. Eliopoulos G. M., Moellering A. E., Reiszner E., Moellering R. C., Jr In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrob Agents Chemother. 1985 Oct;28(4):514–520. doi: 10.1128/aac.28.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Garcia I., Fainstein V., LeBlanc B., Bodey G. P. In vitro activities of new beta-lactam antibiotics against Acinetobacter spp. Antimicrob Agents Chemother. 1983 Aug;24(2):297–299. doi: 10.1128/aac.24.2.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hoy J. F., Rolston K. V., Ho D. H., Alvarez M., Thirolf P., Bodey G. P. In vitro activity of BRL 36650, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1986 Jun;29(6):972–976. doi: 10.1128/aac.29.6.972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. King A., Shannon K., Phillips I. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. J Antimicrob Chemother. 1985 May;15(5):551–558. doi: 10.1093/jac/15.5.551. [DOI] [PubMed] [Google Scholar]
  7. Mandell W., Neu H. C. In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. Antimicrob Agents Chemother. 1986 May;29(5):852–857. doi: 10.1128/aac.29.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rolston K., Guan Z., Bodey G. P., Elting L. Acinetobacter calcoaceticus septicemia in patients with cancer. South Med J. 1985 Jun;78(6):647–651. doi: 10.1097/00007611-198506000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES